The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Active Pharma Ingredient Market Research Report 2021

Global Active Pharma Ingredient Market Research Report 2021

Publishing Date : Oct, 2021

License Type :
 

Report Code : 1630672

No of Pages : 139

Synopsis
The global Active Pharma Ingredient market was valued at US$ XX million in 2020 and is expected to reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
This report focuses on Active Pharma Ingredient volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Active Pharma Ingredient market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Active Pharma Ingredient Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Innovative Active Pharmaceutical Ingredients
Generic Active Pharmaceutical Ingredients

Segment by Application
Oncology
Cardiovascular Disease
Diabetes
Central Nervous System and Neurological Disorders
Endocrinology
Other Therapeutic Applications

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu Hengrui Medicine
Index
1 Active Pharma Ingredient Market Overview
1.1 Product Overview and Scope of Active Pharma Ingredient
1.2 Active Pharma Ingredient Segment by Type
1.2.1 Global Active Pharma Ingredient Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Innovative Active Pharmaceutical Ingredients
1.2.3 Generic Active Pharmaceutical Ingredients
1.3 Active Pharma Ingredient Segment by Application
1.3.1 Global Active Pharma Ingredient Sales Comparison by Application: (2021-2027)
1.3.2 Oncology
1.3.3 Cardiovascular Disease
1.3.4 Diabetes
1.3.5 Central Nervous System and Neurological Disorders
1.3.6 Endocrinology
1.3.7 Other Therapeutic Applications
1.4 Global Active Pharma Ingredient Market Size Estimates and Forecasts
1.4.1 Global Active Pharma Ingredient Revenue 2016-2027
1.4.2 Global Active Pharma Ingredient Sales 2016-2027
1.4.3 Active Pharma Ingredient Market Size by Region: 2016 Versus 2021 Versus 2027

2 Active Pharma Ingredient Market Competition by Manufacturers
2.1 Global Active Pharma Ingredient Sales Market Share by Manufacturers (2016-2021)
2.2 Global Active Pharma Ingredient Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Active Pharma Ingredient Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Active Pharma Ingredient Manufacturing Sites, Area Served, Product Type
2.5 Active Pharma Ingredient Market Competitive Situation and Trends
2.5.1 Active Pharma Ingredient Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Active Pharma Ingredient Players Market Share by Revenue
2.5.3 Global Active Pharma Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Active Pharma Ingredient Retrospective Market Scenario by Region
3.1 Global Active Pharma Ingredient Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Active Pharma Ingredient Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Active Pharma Ingredient Market Facts & Figures by Country
3.3.1 North America Active Pharma Ingredient Sales by Country
3.3.2 North America Active Pharma Ingredient Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Active Pharma Ingredient Market Facts & Figures by Country
3.4.1 Europe Active Pharma Ingredient Sales by Country
3.4.2 Europe Active Pharma Ingredient Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Active Pharma Ingredient Market Facts & Figures by Region
3.5.1 Asia Pacific Active Pharma Ingredient Sales by Region
3.5.2 Asia Pacific Active Pharma Ingredient Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Active Pharma Ingredient Market Facts & Figures by Country
3.6.1 Latin America Active Pharma Ingredient Sales by Country
3.6.2 Latin America Active Pharma Ingredient Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Active Pharma Ingredient Market Facts & Figures by Country
3.7.1 Middle East and Africa Active Pharma Ingredient Sales by Country
3.7.2 Middle East and Africa Active Pharma Ingredient Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Active Pharma Ingredient Historic Market Analysis by Type
4.1 Global Active Pharma Ingredient Sales Market Share by Type (2016-2021)
4.2 Global Active Pharma Ingredient Revenue Market Share by Type (2016-2021)
4.3 Global Active Pharma Ingredient Price by Type (2016-2021)

5 Global Active Pharma Ingredient Historic Market Analysis by Application
5.1 Global Active Pharma Ingredient Sales Market Share by Application (2016-2021)
5.2 Global Active Pharma Ingredient Revenue Market Share by Application (2016-2021)
5.3 Global Active Pharma Ingredient Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Teva Active Pharma Ingredient Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Novartis Active Pharma Ingredient Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Active Pharma Ingredient Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Johnson & Johnson Active Pharma Ingredient Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Mylan Active Pharma Ingredient Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 North China Pharmaceutical Group
6.6.1 North China Pharmaceutical Group Corporation Information
6.6.2 North China Pharmaceutical Group Description and Business Overview
6.6.3 North China Pharmaceutical Group Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.6.4 North China Pharmaceutical Group Active Pharma Ingredient Product Portfolio
6.6.5 North China Pharmaceutical Group Recent Developments/Updates
6.7 Dr. Reddy’s Laboratories
6.6.1 Dr. Reddy’s Laboratories Corporation Information
6.6.2 Dr. Reddy’s Laboratories Description and Business Overview
6.6.3 Dr. Reddy’s Laboratories Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Dr. Reddy’s Laboratories Active Pharma Ingredient Product Portfolio
6.7.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.8 Roche
6.8.1 Roche Corporation Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Roche Active Pharma Ingredient Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 Aurobindo pharma
6.9.1 Aurobindo pharma Corporation Information
6.9.2 Aurobindo pharma Description and Business Overview
6.9.3 Aurobindo pharma Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Aurobindo pharma Active Pharma Ingredient Product Portfolio
6.9.5 Aurobindo pharma Recent Developments/Updates
6.10 Sun Pharmaceutical Industries
6.10.1 Sun Pharmaceutical Industries Corporation Information
6.10.2 Sun Pharmaceutical Industries Description and Business Overview
6.10.3 Sun Pharmaceutical Industries Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Sun Pharmaceutical Industries Active Pharma Ingredient Product Portfolio
6.10.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.11 Boehringer Ingelheim GmbH
6.11.1 Boehringer Ingelheim GmbH Corporation Information
6.11.2 Boehringer Ingelheim GmbH Active Pharma Ingredient Description and Business Overview
6.11.3 Boehringer Ingelheim GmbH Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Boehringer Ingelheim GmbH Active Pharma Ingredient Product Portfolio
6.11.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.12 Bayer
6.12.1 Bayer Corporation Information
6.12.2 Bayer Active Pharma Ingredient Description and Business Overview
6.12.3 Bayer Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Bayer Active Pharma Ingredient Product Portfolio
6.12.5 Bayer Recent Developments/Updates
6.13 BASF
6.13.1 BASF Corporation Information
6.13.2 BASF Active Pharma Ingredient Description and Business Overview
6.13.3 BASF Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.13.4 BASF Active Pharma Ingredient Product Portfolio
6.13.5 BASF Recent Developments/Updates
6.14 DSM
6.14.1 DSM Corporation Information
6.14.2 DSM Active Pharma Ingredient Description and Business Overview
6.14.3 DSM Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.14.4 DSM Active Pharma Ingredient Product Portfolio
6.14.5 DSM Recent Developments/Updates
6.15 Zhejiang Medicine
6.15.1 Zhejiang Medicine Corporation Information
6.15.2 Zhejiang Medicine Active Pharma Ingredient Description and Business Overview
6.15.3 Zhejiang Medicine Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Zhejiang Medicine Active Pharma Ingredient Product Portfolio
6.15.5 Zhejiang Medicine Recent Developments/Updates
6.16 Biocon
6.16.1 Biocon Corporation Information
6.16.2 Biocon Active Pharma Ingredient Description and Business Overview
6.16.3 Biocon Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Biocon Active Pharma Ingredient Product Portfolio
6.16.5 Biocon Recent Developments/Updates
6.17 Johnson Matthey
6.17.1 Johnson Matthey Corporation Information
6.17.2 Johnson Matthey Active Pharma Ingredient Description and Business Overview
6.17.3 Johnson Matthey Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Johnson Matthey Active Pharma Ingredient Product Portfolio
6.17.5 Johnson Matthey Recent Developments/Updates
6.18 Hisun Pharmacy
6.18.1 Hisun Pharmacy Corporation Information
6.18.2 Hisun Pharmacy Active Pharma Ingredient Description and Business Overview
6.18.3 Hisun Pharmacy Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Hisun Pharmacy Active Pharma Ingredient Product Portfolio
6.18.5 Hisun Pharmacy Recent Developments/Updates
6.19 Cambrex
6.19.1 Cambrex Corporation Information
6.19.2 Cambrex Active Pharma Ingredient Description and Business Overview
6.19.3 Cambrex Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Cambrex Active Pharma Ingredient Product Portfolio
6.19.5 Cambrex Recent Developments/Updates
6.20 Shandong Xinhua Pharmaceutical
6.20.1 Shandong Xinhua Pharmaceutical Corporation Information
6.20.2 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Description and Business Overview
6.20.3 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Product Portfolio
6.20.5 Shandong Xinhua Pharmaceutical Recent Developments/Updates
6.21 Lonza group
6.21.1 Lonza group Corporation Information
6.21.2 Lonza group Active Pharma Ingredient Description and Business Overview
6.21.3 Lonza group Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Lonza group Active Pharma Ingredient Product Portfolio
6.21.5 Lonza group Recent Developments/Updates
6.22 Huahai Pharmaceutical
6.22.1 Huahai Pharmaceutical Corporation Information
6.22.2 Huahai Pharmaceutical Active Pharma Ingredient Description and Business Overview
6.22.3 Huahai Pharmaceutical Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Huahai Pharmaceutical Active Pharma Ingredient Product Portfolio
6.22.5 Huahai Pharmaceutical Recent Developments/Updates
6.23 Haerbin Pharmaceutical Group
6.23.1 Haerbin Pharmaceutical Group Corporation Information
6.23.2 Haerbin Pharmaceutical Group Active Pharma Ingredient Description and Business Overview
6.23.3 Haerbin Pharmaceutical Group Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Haerbin Pharmaceutical Group Active Pharma Ingredient Product Portfolio
6.23.5 Haerbin Pharmaceutical Group Recent Developments/Updates
6.24 Cipla
6.24.1 Cipla Corporation Information
6.24.2 Cipla Active Pharma Ingredient Description and Business Overview
6.24.3 Cipla Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.24.4 Cipla Active Pharma Ingredient Product Portfolio
6.24.5 Cipla Recent Developments/Updates
6.25 Tian Yao
6.25.1 Tian Yao Corporation Information
6.25.2 Tian Yao Active Pharma Ingredient Description and Business Overview
6.25.3 Tian Yao Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.25.4 Tian Yao Active Pharma Ingredient Product Portfolio
6.25.5 Tian Yao Recent Developments/Updates
6.26 Lupin
6.26.1 Lupin Corporation Information
6.26.2 Lupin Active Pharma Ingredient Description and Business Overview
6.26.3 Lupin Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.26.4 Lupin Active Pharma Ingredient Product Portfolio
6.26.5 Lupin Recent Developments/Updates
6.27 North East Pharmaceutical
6.27.1 North East Pharmaceutical Corporation Information
6.27.2 North East Pharmaceutical Active Pharma Ingredient Description and Business Overview
6.27.3 North East Pharmaceutical Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.27.4 North East Pharmaceutical Active Pharma Ingredient Product Portfolio
6.27.5 North East Pharmaceutical Recent Developments/Updates
6.28 Albemarle
6.28.1 Albemarle Corporation Information
6.28.2 Albemarle Active Pharma Ingredient Description and Business Overview
6.28.3 Albemarle Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.28.4 Albemarle Active Pharma Ingredient Product Portfolio
6.28.5 Albemarle Recent Developments/Updates
6.29 Shandong Lukang Pharmaceutical
6.29.1 Shandong Lukang Pharmaceutical Corporation Information
6.29.2 Shandong Lukang Pharmaceutical Active Pharma Ingredient Description and Business Overview
6.29.3 Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.29.4 Shandong Lukang Pharmaceutical Active Pharma Ingredient Product Portfolio
6.29.5 Shandong Lukang Pharmaceutical Recent Developments/Updates
6.30 Jiangsu Hengrui Medicine
6.30.1 Jiangsu Hengrui Medicine Corporation Information
6.30.2 Jiangsu Hengrui Medicine Active Pharma Ingredient Description and Business Overview
6.30.3 Jiangsu Hengrui Medicine Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021)
6.30.4 Jiangsu Hengrui Medicine Active Pharma Ingredient Product Portfolio
6.30.5 Jiangsu Hengrui Medicine Recent Developments/Updates

7 Active Pharma Ingredient Manufacturing Cost Analysis
7.1 Active Pharma Ingredient Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Active Pharma Ingredient
7.4 Active Pharma Ingredient Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Active Pharma Ingredient Distributors List
8.3 Active Pharma Ingredient Customers

9 Active Pharma Ingredient Market Dynamics
9.1 Active Pharma Ingredient Industry Trends
9.2 Active Pharma Ingredient Growth Drivers
9.3 Active Pharma Ingredient Market Challenges
9.4 Active Pharma Ingredient Market Restraints

10 Global Market Forecast
10.1 Active Pharma Ingredient Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Active Pharma Ingredient by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Active Pharma Ingredient by Type (2022-2027)
10.2 Active Pharma Ingredient Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Active Pharma Ingredient by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Active Pharma Ingredient by Application (2022-2027)
10.3 Active Pharma Ingredient Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Active Pharma Ingredient by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Active Pharma Ingredient by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Active Pharma Ingredient Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Active Pharma Ingredient Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Active Pharma Ingredient Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Active Pharma Ingredient Covered in This Study
Table 5. Global Active Pharma Ingredient Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Active Pharma Ingredient Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Active Pharma Ingredient Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Active Pharma Ingredient Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Active Pharma Ingredient Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Active Pharma Ingredient Manufacturing Sites and Area Served
Table 11. Manufacturers Active Pharma Ingredient Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Active Pharma Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharma Ingredient as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Active Pharma Ingredient Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Active Pharma Ingredient Sales Market Share by Region (2016-2021)
Table 17. Global Active Pharma Ingredient Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Active Pharma Ingredient Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Active Pharma Ingredient Sales Market Share by Country (2016-2021)
Table 20. North America Active Pharma Ingredient Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Active Pharma Ingredient Revenue Market Share by Country (2016-2021)
Table 22. Europe Active Pharma Ingredient Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Active Pharma Ingredient Sales Market Share by Country (2016-2021)
Table 24. Europe Active Pharma Ingredient Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Active Pharma Ingredient Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Active Pharma Ingredient Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Active Pharma Ingredient Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Active Pharma Ingredient Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Active Pharma Ingredient Revenue Market Share by Region (2016-2021)
Table 30. Latin America Active Pharma Ingredient Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Active Pharma Ingredient Sales Market Share by Country (2016-2021)
Table 32. Latin America Active Pharma Ingredient Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Active Pharma Ingredient Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Active Pharma Ingredient Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Active Pharma Ingredient Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Active Pharma Ingredient Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Active Pharma Ingredient Revenue Market Share by Country (2016-2021)
Table 38. Global Active Pharma Ingredient Sales (K Pcs) by Type (2016-2021)
Table 39. Global Active Pharma Ingredient Sales Market Share by Type (2016-2021)
Table 40. Global Active Pharma Ingredient Revenue (Million US$) by Type (2016-2021)
Table 41. Global Active Pharma Ingredient Revenue Share by Type (2016-2021)
Table 42. Global Active Pharma Ingredient Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Active Pharma Ingredient Sales (K Pcs) by Application (2016-2021)
Table 44. Global Active Pharma Ingredient Sales Market Share by Application (2016-2021)
Table 45. Global Active Pharma Ingredient Revenue (Million US$) by Application (2016-2021)
Table 46. Global Active Pharma Ingredient Revenue Share by Application (2016-2021)
Table 47. Global Active Pharma Ingredient Price (USD/Pcs) by Application (2016-2021)
Table 48. Teva Corporation Information
Table 49. Teva Description and Business Overview
Table 50. Teva Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Teva Active Pharma Ingredient Product
Table 52. Teva Recent Developments/Updates
Table 53. Novartis Corporation Information
Table 54. Novartis Description and Business Overview
Table 55. Novartis Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Novartis Active Pharma Ingredient Product
Table 57. Novartis Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Pfizer Active Pharma Ingredient Product
Table 62. Pfizer Recent Developments/Updates
Table 63. Johnson & Johnson Corporation Information
Table 64. Johnson & Johnson Description and Business Overview
Table 65. Johnson & Johnson Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Johnson & Johnson Active Pharma Ingredient Product
Table 67. Johnson & Johnson Recent Developments/Updates
Table 68. Mylan Corporation Information
Table 69. Mylan Description and Business Overview
Table 70. Mylan Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Mylan Active Pharma Ingredient Product
Table 72. Mylan Recent Developments/Updates
Table 73. North China Pharmaceutical Group Corporation Information
Table 74. North China Pharmaceutical Group Description and Business Overview
Table 75. North China Pharmaceutical Group Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. North China Pharmaceutical Group Active Pharma Ingredient Product
Table 77. North China Pharmaceutical Group Recent Developments/Updates
Table 78. Dr. Reddy’s Laboratories Corporation Information
Table 79. Dr. Reddy’s Laboratories Description and Business Overview
Table 80. Dr. Reddy’s Laboratories Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Dr. Reddy’s Laboratories Active Pharma Ingredient Product
Table 82. Dr. Reddy’s Laboratories Recent Developments/Updates
Table 83. Roche Corporation Information
Table 84. Roche Description and Business Overview
Table 85. Roche Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Roche Active Pharma Ingredient Product
Table 87. Roche Recent Developments/Updates
Table 88. Aurobindo pharma Corporation Information
Table 89. Aurobindo pharma Description and Business Overview
Table 90. Aurobindo pharma Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Aurobindo pharma Active Pharma Ingredient Product
Table 92. Aurobindo pharma Recent Developments/Updates
Table 93. Sun Pharmaceutical Industries Corporation Information
Table 94. Sun Pharmaceutical Industries Description and Business Overview
Table 95. Sun Pharmaceutical Industries Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Sun Pharmaceutical Industries Active Pharma Ingredient Product
Table 97. Sun Pharmaceutical Industries Recent Developments/Updates
Table 98. Boehringer Ingelheim GmbH Corporation Information
Table 99. Boehringer Ingelheim GmbH Description and Business Overview
Table 100. Boehringer Ingelheim GmbH Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Boehringer Ingelheim GmbH Active Pharma Ingredient Product
Table 102. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 103. Bayer Corporation Information
Table 104. Bayer Description and Business Overview
Table 105. Bayer Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Bayer Active Pharma Ingredient Product
Table 107. Bayer Recent Developments/Updates
Table 108. BASF Corporation Information
Table 109. BASF Description and Business Overview
Table 110. BASF Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. BASF Active Pharma Ingredient Product
Table 112. BASF Recent Developments/Updates
Table 113. DSM Corporation Information
Table 114. DSM Description and Business Overview
Table 115. DSM Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. DSM Active Pharma Ingredient Product
Table 117. DSM Recent Developments/Updates
Table 118. Zhejiang Medicine Corporation Information
Table 119. Zhejiang Medicine Description and Business Overview
Table 120. Zhejiang Medicine Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. Zhejiang Medicine Active Pharma Ingredient Product
Table 122. Zhejiang Medicine Recent Developments/Updates
Table 123. Biocon Corporation Information
Table 124. Biocon Description and Business Overview
Table 125. Biocon Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 126. Biocon Active Pharma Ingredient Product
Table 127. Biocon Recent Developments/Updates
Table 128. Johnson Matthey Corporation Information
Table 129. Johnson Matthey Description and Business Overview
Table 130. Johnson Matthey Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 131. Johnson Matthey Active Pharma Ingredient Product
Table 132. Johnson Matthey Recent Developments/Updates
Table 133. Hisun Pharmacy Corporation Information
Table 134. Hisun Pharmacy Description and Business Overview
Table 135. Hisun Pharmacy Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 136. Hisun Pharmacy Active Pharma Ingredient Product
Table 137. Hisun Pharmacy Recent Developments/Updates
Table 138. Cambrex Corporation Information
Table 139. Cambrex Description and Business Overview
Table 140. Cambrex Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 141. Cambrex Active Pharma Ingredient Product
Table 142. Cambrex Recent Developments/Updates
Table 143. Shandong Xinhua Pharmaceutical Corporation Information
Table 144. Shandong Xinhua Pharmaceutical Description and Business Overview
Table 145. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 146. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Product
Table 147. Shandong Xinhua Pharmaceutical Recent Developments/Updates
Table 148. Lonza group Corporation Information
Table 149. Lonza group Description and Business Overview
Table 150. Lonza group Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 151. Lonza group Active Pharma Ingredient Product
Table 152. Lonza group Recent Developments/Updates
Table 153. Huahai Pharmaceutical Corporation Information
Table 154. Huahai Pharmaceutical Description and Business Overview
Table 155. Huahai Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 156. Huahai Pharmaceutical Active Pharma Ingredient Product
Table 157. Huahai Pharmaceutical Recent Developments/Updates
Table 158. Haerbin Pharmaceutical Group Corporation Information
Table 159. Haerbin Pharmaceutical Group Description and Business Overview
Table 160. Haerbin Pharmaceutical Group Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 161. Haerbin Pharmaceutical Group Active Pharma Ingredient Product
Table 162. Haerbin Pharmaceutical Group Recent Developments/Updates
Table 163. Cipla Corporation Information
Table 164. Cipla Description and Business Overview
Table 165. Cipla Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 166. Cipla Active Pharma Ingredient Product
Table 167. Cipla Recent Developments/Updates
Table 168. Tian Yao Corporation Information
Table 169. Tian Yao Description and Business Overview
Table 170. Tian Yao Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 171. Tian Yao Active Pharma Ingredient Product
Table 172. Tian Yao Recent Developments/Updates
Table 173. Lupin Corporation Information
Table 174. Lupin Description and Business Overview
Table 175. Lupin Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 176. Lupin Active Pharma Ingredient Product
Table 177. Lupin Recent Developments/Updates
Table 178. North East Pharmaceutical Corporation Information
Table 179. North East Pharmaceutical Description and Business Overview
Table 180. North East Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 181. North East Pharmaceutical Active Pharma Ingredient Product
Table 182. North East Pharmaceutical Recent Developments/Updates
Table 183. Albemarle Corporation Information
Table 184. Albemarle Description and Business Overview
Table 185. Albemarle Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 186. Albemarle Active Pharma Ingredient Product
Table 187. Albemarle Recent Developments/Updates
Table 188. Shandong Lukang Pharmaceutical Corporation Information
Table 189. Shandong Lukang Pharmaceutical Description and Business Overview
Table 190. Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 191. Shandong Lukang Pharmaceutical Active Pharma Ingredient Product
Table 192. Shandong Lukang Pharmaceutical Recent Developments/Updates
Table 193. Jiangsu Hengrui Medicine Corporation Information
Table 194. Jiangsu Hengrui Medicine Description and Business Overview
Table 195. Jiangsu Hengrui Medicine Active Pharma Ingredient Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 196. Jiangsu Hengrui Medicine Active Pharma Ingredient Product
Table 197. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 198. Production Base and Market Concentration Rate of Raw Material
Table 199. Key Suppliers of Raw Materials
Table 200. Active Pharma Ingredient Distributors List
Table 201. Active Pharma Ingredient Customers List
Table 202. Active Pharma Ingredient Market Trends
Table 203. Active Pharma Ingredient Growth Drivers
Table 204. Active Pharma Ingredient Market Challenges
Table 205. Active Pharma Ingredient Market Restraints
Table 206. Global Active Pharma Ingredient Sales Forecast by Type (2022-2027) & (K Pcs)
Table 207. Global Active Pharma Ingredient Sales Market Share Forecast by Type (2022-2027)
Table 208. Global Active Pharma Ingredient Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 209. Global Active Pharma Ingredient Revenue Market Share Forecast by Type (2022-2027)
Table 210. Global Active Pharma Ingredient Sales Forecast by Application (2022-2027) & (K Pcs)
Table 211. Global Active Pharma Ingredient Sales Market Share Forecast by Application (2022-2027)
Table 212. Global Active Pharma Ingredient Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 213. Global Active Pharma Ingredient Revenue Market Share Forecast by Application (2022-2027)
Table 214. Global Active Pharma Ingredient Sales Forecast by Region (2022-2027) & (K Pcs)
Table 215. Global Active Pharma Ingredient Sales Market Share Forecast by Region (2022-2027)
Table 216. Global Active Pharma Ingredient Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 217. Global Active Pharma Ingredient Revenue Market Share Forecast by Region (2022-2027)
Table 218. Research Programs/Design for This Report
Table 219. Key Data Information from Secondary Sources
Table 220. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Active Pharma Ingredient
Figure 2. Global Active Pharma Ingredient Market Share by Type in 2020 & 2027
Figure 3. Innovative Active Pharmaceutical Ingredients Product Picture
Figure 4. Generic Active Pharmaceutical Ingredients Product Picture
Figure 5. Global Active Pharma Ingredient Market Share by Application in 2020 & 2027
Figure 6. Oncology
Figure 7. Cardiovascular Disease
Figure 8. Diabetes
Figure 9. Central Nervous System and Neurological Disorders
Figure 10. Endocrinology
Figure 11. Other Therapeutic Applications
Figure 12. Global Active Pharma Ingredient Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Active Pharma Ingredient Market Size 2016-2027 (US$ Million)
Figure 14. Global Active Pharma Ingredient Sales 2016-2027 (K Pcs)
Figure 15. Global Active Pharma Ingredient Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Active Pharma Ingredient Sales Share by Manufacturers in 2020
Figure 17. Global Active Pharma Ingredient Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Active Pharma Ingredient Players: Market Share by Revenue in 2020
Figure 19. Active Pharma Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Active Pharma Ingredient Sales Market Share by Region (2016-2021)
Figure 21. Global Active Pharma Ingredient Sales Market Share by Region in 2020
Figure 22. Global Active Pharma Ingredient Revenue Market Share by Region (2016-2021)
Figure 23. Global Active Pharma Ingredient Revenue Market Share by Region in 2020
Figure 24. U.S. Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. China Taiwan Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Active Pharma Ingredient Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Active Pharma Ingredient by Type (2016-2021)
Figure 47. Sales Market Share of Active Pharma Ingredient by Application (2016-2021)
Figure 48. Sales Market Share of Active Pharma Ingredient by Application in 2020
Figure 49. Revenue Share of Active Pharma Ingredient by Application (2016-2021)
Figure 50. Revenue Share of Active Pharma Ingredient by Application in 2020
Figure 51. Manufacturing Cost Structure of Active Pharma Ingredient
Figure 52. Manufacturing Process Analysis of Active Pharma Ingredient
Figure 53. Active Pharma Ingredient Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’